QUANTUM FERTILITY

The Menstrual Health Monitoring Study will measure four key reproductive hormones in the urine to characterize patterns that predict and confirm ovulation, referenced to the gold-standard of the ultrasound day of ovulation in participants with regular cycles. These normal cycles will provide a reference for comparison to the long, irregular and sometimes anovulatory cycles in polycystic ovarian syndrome (PCOS) as well as in athletes with irregular cycles. Other clinical signs in the cycle (menstrual bleeding, temperature) will also be referenced to hormonal changes. Other special circumstances (e.g. the perimenopause and postpartum transitions) will be analyzed in pilot datasets for future study planning.

Also known as: Quantum Fertility Inc

Primary location: Calgary